Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Pitisuttithum, Punnee"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-20 z 20
    Tytuł:
    Accuracy of Clinical Diagnosis of Dengue Episodes in the RV144 HIV Vaccine Efficacy Trial in Thailand.
    Autorzy:
    Pitisuttithum, Punnee
    Rerks-Ngarm, Supachai
    Stablein, Donald
    Dawson, Peter
    Nitayaphan, Sorachai
    Kaewkungwal, Jaranit
    Michael, Nelson L.
    Kim, Jerome H.
    Robb, Merlin L.
    O’Connell, Robert J.
    Yoon, In-Kyu
    Fernandez, Stefan
    Excler, Jean-Louis
    Pokaż więcej
    Źródło:
    PLoS ONE. May2015, Vol. 10 Issue 5, p1-10. 10p.
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease.
    Autorzy:
    Pasin, Chloé
    Halloran, M. Elizabeth
    Gilbert, Peter B.
    Langevin, Edith
    Ochiai, R. Leon
    Pitisuttithum, Punnee
    Capeding, Maria Rosario
    Carrasquilla, Gabriel
    Frago, Carina
    Cortés, Margarita
    Chambonneau, Laurent
    Moodie, Zoe
    Pokaż więcej
    Temat:
    ENDEMIC diseases
    MENINGOCOCCAL vaccines
    VACCINE effectiveness
    PROPORTIONAL hazards models
    Źródło:
    PLoS ONE; 12/13/2018, Vol. 13 Issue 12, p1-16, 16p
    Przedsiębiorstwo/ jednostka:
    WORLD Meteorological Organization
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2.
    Autorzy:
    Dondorp, Arjen M.
    Desakorn, Varunee
    Pongtavornpinyo, Wirichada
    Sahassananda, Duangjai
    Silamut, Kamolrat
    Chotivanich, Kesinee
    Newton, Paul N.
    Pitisuttithum, Punnee
    Smithyman, A. M.
    White, Nicholas J.
    Day, Nicholas P. J.
    Pokaż więcej
    Temat:
    MALARIA
    BLOOD parasites
    ERYTHROCYTES
    ENZYME-linked immunosorbent assay
    PATIENTS
    Źródło:
    PLoS Medicine; Aug2005, Vol. 2 Issue 8, p788-797, 10p, 2 Charts, 3 Graphs
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Correction: Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2.
    Autorzy:
    Dondorp, Arjen M.
    Desakorn, Varunee
    Pongtavornpinyo, Wirichada
    Sahassananda, Duangjai
    Silamut, Kamolrat
    Chotivanich, Kesinee
    Newton, Paul N.
    Pitisuttithum, Punnee
    Smithyman, A. M.
    White, Nicholas J.
    Day, Nicholas P. J.
    Pokaż więcej
    Temat:
    BIOMASS estimation
    MALARIA
    Źródło:
    PLoS Medicine; Oct2005, Vol. 2 Issue 10, p1047-1047, 1p
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques.
    Autorzy:
    Santra S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
    Tomaras GD; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Warrier R; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
    Nicely NI; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Liao HX; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Pollara J; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Liu P; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Alam SM; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Zhang R; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Cocklin SL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
    Shen X; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Duffy R; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Xia SM; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Schutte RJ; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Pemble Iv CW; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Dennison SM; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Li H; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
    Chao A; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
    Vidnovic K; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
    Evans A; Department of Medicine, St Mary's Campus, Imperial College London, London, United Kingdom.
    Klein K; Department of Medicine, St Mary's Campus, Imperial College London, London, United Kingdom.
    Kumar A; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Robinson J; Department of Pediatrics, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
    Landucci G; Division of Infectious Diseases, Department of Medicine, University of California, Irvine, Irvine, California, United States of America.
    Forthal DN; Division of Infectious Diseases, Department of Medicine, University of California, Irvine, Irvine, California, United States of America.
    Montefiori DC; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Kaewkungwal J; Tropical Hygiene, Mahidol University, Bangkok, Thailand.
    Nitayaphan S; Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.
    Pitisuttithum P; Clinical Tropical Medicine, Mahidol University, Bangkok, Thailand.
    Rerks-Ngarm S; Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.
    Robb ML; US Military Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
    Michael NL; US Military Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
    Kim JH; US Military Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
    Soderberg KA; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Giorgi EE; Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
    Blair L; Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
    Korber BT; Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
    Moog C; U1109, INSERM University of Strasbourg, Strasbourg, Alsace, France.
    Shattock RJ; Department of Medicine, St Mary's Campus, Imperial College London, London, United Kingdom.
    Letvin NL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
    Schmitz JE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
    Moody MA; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Gao F; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Ferrari G; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Shaw GM; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
    Haynes BF; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2015 Aug 03; Vol. 11 (8), pp. e1005042. Date of Electronic Publication: 2015 Aug 03 (Print Publication: 2015).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antibodies, Monoclonal/*immunology
    Antibodies, Viral/*immunology
    Simian Acquired Immunodeficiency Syndrome/*prevention & control
    Simian Immunodeficiency Virus/*immunology
    Viral Envelope Proteins/*immunology
    Animals ; CD4-Positive T-Lymphocytes/immunology ; Fluorescent Antibody Technique ; HIV-1/immunology ; Humans ; Intestinal Mucosa/virology ; Macaca mulatta ; Protein Conformation ; Rectum ; Reverse Transcriptase Polymerase Chain Reaction ; Surface Plasmon Resonance ; Viral Envelope Proteins/chemistry
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.
    Autorzy:
    Edlefsen PT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Rolland M; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
    Hertz T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; The Shraga Segal Dept. of Microbiology, Immunology and Genetics, Faculty of Health Sciences, and The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
    Tovanabutra S; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
    Gartland AJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    deCamp AC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Magaret CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Ahmed H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Gottardo R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Juraska M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    McCoy C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Larsen BB; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
    Sanders-Buell E; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
    Carrico C; Department of Biochemistry, University of Washington, Seattle, Washington, United States of America; IAVI Neutralizing Antibody Center and Department of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, California, United States of America.
    Menis S; Department of Biochemistry, University of Washington, Seattle, Washington, United States of America; IAVI Neutralizing Antibody Center and Department of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, California, United States of America.
    Kijak GH; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
    Bose M; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
    Arroyo MA; Royal Thai Army Component, AFRIMS, Bangkok, Thailand.
    O'Connell RJ; US Army Component, AFRIMS, Bangkok, Thailand.
    Nitayaphan S; Royal Thai Army Component, AFRIMS, Bangkok, Thailand.
    Pitisuttithum P; Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
    Kaewkungwal J; Royal Thai Army Component, AFRIMS, Bangkok, Thailand.
    Rerks-Ngarm S; CDC Department, Thai Ministry of Public Health, Nonthaburi, Thailand.
    Robb ML; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
    Kirys T; Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America.
    Georgiev IS; Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America.
    Kwong PD; Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America.
    Scheffler K; Department of Medicine, University of California, San Diego, La Jolla, California, United States of America.
    Pond SL; Department of Medicine, University of California, San Diego, La Jolla, California, United States of America.
    Carlson JM; eSience Research Group, Microsoft Research, Redmond, Washington, United States of America.
    Michael NL; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
    Schief WR; Department of Biochemistry, University of Washington, Seattle, Washington, United States of America; IAVI Neutralizing Antibody Center and Department of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, California, United States of America; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
    Mullins JI; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
    Kim JH; US Military HIV Research Program, Silver Spring, Maryland, United States of America.
    Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Pokaż więcej
    Corporate Authors:
    RV144 Sequencing Team
    Źródło:
    PLoS computational biology [PLoS Comput Biol] 2015 Feb 03; Vol. 11 (2), pp. e1003973. Date of Electronic Publication: 2015 Feb 03 (Print Publication: 2015).
    Typ publikacji:
    Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    AIDS Vaccines/*immunology
    HIV Infections/*immunology
    HIV Infections/*virology
    HIV-1/*genetics
    HIV-1/*immunology
    Human Immunodeficiency Virus Proteins/*chemistry
    AIDS Vaccines/genetics ; Binding Sites/genetics ; Genome, Viral/genetics ; HIV Infections/prevention & control ; Human Immunodeficiency Virus Proteins/genetics ; Humans ; Models, Molecular ; Molecular Sequence Data ; Sequence Alignment ; Sequence Analysis, Protein
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial.
    Autorzy:
    Gottardo R; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
    Bailer RT
    Korber BT
    Gnanakaran S
    Phillips J
    Shen X
    Tomaras GD
    Turk E
    Imholte G
    Eckler L
    Wenschuh H
    Zerweck J
    Greene K
    Gao H
    Berman PW
    Francis D
    Sinangil F
    Lee C
    Nitayaphan S
    Rerks-Ngarm S
    Kaewkungwal J
    Pitisuttithum P
    Tartaglia J
    Robb ML
    Michael NL
    Kim JH
    Zolla-Pazner S
    Haynes BF
    Mascola JR
    Self S
    Gilbert P
    Montefiori DC
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2013 Sep 26; Vol. 8 (9), pp. e75665. Date of Electronic Publication: 2013 Sep 26 (Print Publication: 2013).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    AIDS Vaccines/*immunology
    Epitopes/*immunology
    HIV Envelope Protein gp120/*genetics
    HIV Envelope Protein gp120/*immunology
    Immunoglobulin G/*blood
    Amino Acid Sequence ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/immunology ; Antigens, Viral/immunology ; B-Lymphocytes/immunology ; Case-Control Studies ; HIV Antibodies/blood ; HIV Antibodies/immunology ; HIV Envelope Protein gp41/immunology ; HIV Infections/blood ; HIV Infections/immunology ; HIV Infections/prevention & control ; HIV-1/genetics ; HIV-1/immunology ; Humans ; Immunoglobulin A/immunology ; Immunoglobulin G/immunology ; Molecular Sequence Data ; Risk ; Sequence Alignment
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Clinical factors for severity of Plasmodium falciparum malaria in hospitalized adults in Thailand.
    Autorzy:
    Sagaki P; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
    Thanachartwet V
    Desakorn V
    Sahassananda D
    Chamnanchanunt S
    Chierakul W
    Pitisuttithum P
    Ruangkanchanasetr P
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2013 Aug 12; Vol. 8 (8), pp. e71503. Date of Electronic Publication: 2013 Aug 12 (Print Publication: 2013).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Inpatients*
    Severity of Illness Index*
    Malaria, Falciparum/*epidemiology
    Adult ; Case-Control Studies ; Critical Care/statistics & numerical data ; Female ; Humans ; Intensive Care Units ; Malaria, Falciparum/diagnosis ; Malaria, Falciparum/therapy ; Male ; Outcome Assessment, Health Care ; Retrospective Studies ; Thailand/epidemiology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    AIDS vaccine for Asia Network (AVAN): expanding the regional role in developing HIV vaccines.
    Autorzy:
    Kent SJ; University of Melbourne, Parkville, Victoria, Australia.
    Cooper DA
    Chhi Vun M
    Shao Y
    Zhang L
    Ganguly N
    Bela B
    Tamashiro H
    Ditangco R
    Rerks-Ngarm S
    Pitisuttithum P
    Van Kinh N
    Bernstein A
    Osmanov S
    Pokaż więcej
    Corporate Authors:
    AIDS Vaccine for Asia Network investigators and supporters
    Źródło:
    PLoS medicine [PLoS Med] 2010 Sep 21; Vol. 7 (9), pp. e1000331. Date of Electronic Publication: 2010 Sep 21.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    AIDS Vaccines*
    HIV Infections/*prevention & control
    Asia ; Biomedical Research ; Clinical Trials as Topic ; Global Health ; HIV Infections/immunology ; Humans ; International Cooperation ; Pandemics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-20 z 20

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies